Chemed Reports Q4 EPS of $0.98 vs. $1.05


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


Chemed Corporation (NYSE: CHE), which operates VITAS Healthcare Corporation reported financial results for its fourth quarter ended December 31, 2010.

  • Revenue increased 10.9% to $336 million
  • Net Income increased 25.8% to $22.6 million
  • Adjusted Net Income increased 15.1% to $27.9 million 
  • EPS $0.98 


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: EarningsNewsHealth CareHealth Care Services